You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

escalating doses

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sickle Cell Disease, Hb-SS Disease, Hemoglobin S Trial run by the National Heart, Lung, and Blood Institute (NHLBI)

Not yet recruiting
  • Sickle Cell Disease
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 21, 2023

Multiple Myeloma Trial in Hackensack (Thalidomide+Melphalan +Bortezomib+stem cell transplant)

Completed
Has Results
  • Multiple Myeloma
  • Thalidomide+Melphalan +Bortezomib+stem cell transplant
  • Hackensack, New Jersey
    John Theurer Cancer Center at Hackensack University Medical Cent
Dec 16, 2022

T2DM (Type 2 Diabetes) Trial in Beijing (HSK7653, Placebo)

Completed
  • T2DM (Type 2 Diabetes Mellitus)
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Aug 1, 2023

Relapsed or Refractory Hematologic Malignancies Trial in Chicago (Omacetaxine, Venetoclax)

Recruiting
  • Relapsed or Refractory Hematologic Malignancies
  • Chicago, Illinois
    University of Illinois Cancer Center
Sep 27, 2022

Healthy Trial in Saint Petersburg (BCD-180, dose 1, BCD-180, dose 2, BCD-180, dose 3)

Recruiting
  • Healthy
  • BCD-180, dose 1
  • +6 more
  • Saint Petersburg, Russian Federation
    X7 Clinical Research
Jun 2, 2022

Lung Cancer Trial in Houston (Cisplatin, Amifostine)

Active, not recruiting
  • Lung Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 29, 2022

Melanoma (Skin) Trial in Tampa (MART-1, NY-ESO-1, gp100:209-217(210M))

Completed
  • Melanoma (Skin)
  • MART-1
  • +5 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 17, 2023

Pulmonary Arterial Hypertension Trial (PF-07868489, Placebo for PF-07868489)

Not yet recruiting
  • Pulmonary Arterial Hypertension
  • (no location specified)
Nov 14, 2023

Advanced Solid Tumors Trial (SIM0348)

Not yet recruiting
  • Advanced Solid Tumors
  • (no location specified)
Feb 6, 2023

Postpartum Depression Trial in Adelaide (BRII-297, Placebo)

Not yet recruiting
  • Postpartum Depression
  • Adelaide, South Australia, Australia
    CMAX
May 3, 2023

Melanoma (Skin) Trial in Tampa (biological, drug, procedure)

Active, not recruiting
  • Melanoma (Skin)
  • NY-ESO-1 157-165 (165V)
  • +5 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 17, 2023

Multiple Sclerosis Trial in San Antonio (PIPE-791, Placebo)

Recruiting
  • Multiple Sclerosis
  • San Antonio, Texas
    Worldwide Clinical Trials
Jul 31, 2023

Alzheimer Trial (RB-ADSC)

Not yet recruiting
  • Alzheimer Disease
  • RB-ADSC
  • (no location specified)
Dec 19, 2022

Celiac Disease Trial in Turku, Oslo (TPM502, Placebo)

Recruiting
  • Celiac Disease
  • Turku, Finland
  • +1 more
Jan 23, 2023

Solid Tumor, Unspecified, Adult Trial in Singapore (177Lu-LNC1004 Injection group 1 radionuclide therapy, 177Lu-LNC1004

Not yet recruiting
  • Solid Tumor, Unspecified, Adult
  • 177Lu-LNC1004 Injection group 1 radionuclide therapy
  • +3 more
  • Singapore, Singapore
    National University Cancer Institute, Singapore National Univers
Feb 1, 2023

Complement Deficiencies Trial (CSL040, Placebo)

Not yet recruiting
  • Complement Deficiencies
  • (no location specified)
Jul 6, 2023

Hiv Trial in Philadelphia (Autologous CD4 T-Cells)

Completed
Has Results
  • Hiv
  • Autologous CD4 T-Cells
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Nov 13, 2022

NSCLC Metastatic Trial in La Jolla (Nivolumab + Plinabulin)

Active, not recruiting
  • Non-small Cell Lung Cancer Metastatic
  • Nivolumab + Plinabulin
  • La Jolla, California
    UC San Diego Moores Cancer Center
Nov 21, 2022

Atherosclerosis, Ischemic Stroke Trial in Nottingham (SP-8356, Placebo)

Terminated
  • Atherosclerosis
  • Ischemic Stroke
  • Nottingham, Mere Way Ruddington Fields Ruddington, United Kingdom
    Quotient Sciences
Oct 6, 2022

Gout Trial in Grafton, Christchurch (PRX-115, Placebo)

Not yet recruiting
  • Gout
  • Grafton, Auckland, New Zealand
  • +1 more
Feb 16, 2023

Scabies Trial (Oral ivermectin, Permethrin Cream, Placebo tablet)

Not yet recruiting
  • Scabies
  • Oral ivermectin
  • +3 more
  • (no location specified)
Jan 19, 2023

Spinal Muscular Atrophy (SMA) Trial in Ekaterinburg, Moscow, Saint Petersburg (ANB-004, dose 1, ANB-004, dose 2, ANB-004, dose

Recruiting
  • Spinal Muscular Atrophy (SMA)
  • ANB-004, dose 1
  • +2 more
  • Ekaterinburg, Russian Federation
  • +5 more
Feb 17, 2023

Chronic Myeloid Leukemia (CML), Pancreatic Ca, Colon/Rectal Ca Trial run by the National Heart, Lung, and Blood Institute

Completed
  • Chronic Myeloid Leukemia (CML)
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 31, 2022

Multiple Myeloma Trial in Worldwide (RO7425781)

Recruiting
  • Multiple Myeloma
  • North Melbourne, Victoria, Australia
  • +15 more
Jan 19, 2023

Neuroblastoma Trial in New York (adjuvant OPT-821 in a vaccine containing two antigens (GD2L and GD3L) covalently linked to KLH,

Active, not recruiting
  • Neuroblastoma
  • adjuvant OPT-821 in a vaccine containing two antigens (GD2L and GD3L) covalently linked to KLH
  • oral β-glucan
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 11, 2021